TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05098509

A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi Syndrome

Cause of deathFunding or business, also safety Automatic label, confidence 0.5, unverified. How labels are made.
“Due to a change in corporate priorities, this study was voluntarily terminated by the Sponsor for reasons other than safety”

The sponsor’s own words in the registry.

Life of this trial

2021202220232024Registered2021-09-22Started2022-04-13Primary completion2022-10-06Stopped2022-10-31Results posted2023-10-19

Vital statistics

Status
Terminated
Phase
Phase 2, Phase 3
Sponsor
Radius Pharmaceuticals, Inc.
Sponsor type
Industry
Conditions
Prader-Willi Syndrome
Interventions
RAD011; Placebo
Participants
4
Sites
8
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.